Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/7253
Tipo: Artigo de Periódico
Título: Induction of cancer cell death by apoptosis and slow release of 5-fluoracil from metal-organic frameworks Cu-BTC
Autor(es): Lucena, Flávia Raquel Santos
Araújo, Larissa C.C. de
Rodrigues, Maria do D.
Silva, Teresinha G. da
Pereira, Valéria R.A.
Militão, Gardênia C.G.
Fontes, Danilo A.F.
Rolim-Neto, Pedro J.
Silva, Fausthon F. da
Nascimento, Silene C.
Palavras-chave: Apoptose;Cancro;Morte Celular
Data do documento: Out-2013
Instituição/Editor/Publicador: Biomedicine & Pharmacotherapy
Citação: LUCENA, F. R. S. et al. Induction of cancer cell death by apoptosis and slow release of 5-fluoracil from metal-organic frameworks Cu-BTC. Biomedicine & Pharmacotherapy, Paris, v. 67, n. 8, p. 707-713, out. 2013.
Abstract: This study aimed to evaluate the mechanism associated with cytotoxic activity displayed by the drug 5- fluorouracil incorporated in Cu-BTC MOF and its slow delivery from the Cu-BTC MOF. Structural characterization encompasses elemental analysis (CHNS), differential scanning calorimetry (DSC), thermogravimetric analysis (TG/DTG), Fournier transform infrared (FIT-IR) and X-ray diffraction (XRD) was performed to verify the process of association between the drug 5-FU and Cu-BTC MOF. Flow cytometry was done to indicate that apoptosis is the mechanism responsible for the cell death. The release profile of the drug 5-FU from Cu-BTC MOF for 48 hours was obeisant. Also, the anti-inflammatory activity was evaluated by the peritonitis testing and the production of nitric oxide and pro-inflammatory cytokines were measured. The chemical characterization of the material indicated the presence of drug associated with the coordination network in a proportion of 0.82 g 5-FU per 1.0 g of Cu-BTC MOF. The cytotoxic tests were carried out against four cell lines: NCI-H292, MCF-7, HT29 and HL60. The Cu-BTC MOF associated drug was extremely cytotoxic against the human breast cancer adenocarcinoma (MCF- 7) cell line and against human acute promyelocytic leukemia cells (HL60), cancer cells were killed by apoptosis mechanisms. The drug demonstrated a slow release profile where 82% of the drug was released in 48 hours. The results indicated that the drug incorporated in Cu-BTC MOF decreased significantly the number of leukocytes in the peritoneal cavity of rodents as well as reduced levels of cytokines and nitric oxide production.
URI: http://www.repositorio.ufc.br/handle/riufc/7253
ISSN: 0753-3322 Impresso
1950-6007 On line
Aparece nas coleções:DFIFA - Artigos publicados em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2013_art_gcgmilitao.pdf1,06 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.